At #AACR26, L. Wang of Rujin Hospital presented,” ABO2203, a messenger RNA encoding a CD3×CD19 T cell engager, for relapsed/refractory B cell non-Hodgkin lymphoma: Preliminary results from first-in-human study”. To learn about a new dual-targeting strategy using CD22 CAR T cells